Page last updated: 2024-08-22

fructosamine and mosapride

fructosamine has been researched along with mosapride in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asakawa, A; Inui, A; Kasuga, M; Komatsu, Y; Kotani, K; Nishimura, R; Takao, F; Ueno, N	1

Trials

1 trial(s) available for fructosamine and mosapride

Article	Year
Mosapride, a 5HT-4 receptor agonist, improves insulin sensitivity and glycaemic control in patients with Type II diabetes mellitus. Diabetologia, 2002, Volume: 45, Issue:6 Topics: Base Sequence; Benzamides; Blood Glucose; Diabetes Mellitus, Type 2; DNA Primers; Female; Fructosamine; Gastrointestinal Agents; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Male; Middle Aged; Morpholines; Placebos; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Reverse Transcriptase Polymerase Chain Reaction; Serotonin Receptor Agonists	2002

Article

Year

Mosapride, a 5HT-4 receptor agonist, improves insulin sensitivity and glycaemic control in patients with Type II diabetes mellitus.

Diabetologia, 2002, Volume: 45, Issue:6

Topics: Base Sequence; Benzamides; Blood Glucose; Diabetes Mellitus, Type 2; DNA Primers; Female; Fructosamine; Gastrointestinal Agents; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Male; Middle Aged; Morpholines; Placebos; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Reverse Transcriptase Polymerase Chain Reaction; Serotonin Receptor Agonists

2002